CRx-102 Osteoarthritis Multicenter Evaluation Trial

NCT00521989 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

279

Enrollment

INDUSTRY

Sponsor class

Stopped CRx-102-006 study results, negative

Conditions

Knee Osteoarthritis

Interventions

DRUG: CRx-102 (2.7/90)
DRUG: Prednisolone
DRUG: Placebo
DRUG: CRx-102 (2.7/180)
DRUG: CRx-102 (2.7/360)

Sponsor

Zalicus